Follow-up of adults in Shanghai with metabolic, heart and kidney conditions
Follows adults in Shanghai with diabetes, obesity, high blood pressure and related conditions.
Plain-language title generated from the registry record
Registry title: Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
Key facts
- Where
- Shanghai, ChinaSee the site
Where in China
- Shanghai Changzheng HospitalShanghai, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Shanghai Changzheng Hospital
- Trial code
- NCT07043166
- Record updated
- 8 September 2025
- Original description
The main purpose of this study is to conduct follow-up assessments and update the cardiorenal outcomes among the STONE cohort that was established during 2016-2017. The secondary aim is to compare metabolic risk factors, metabolic disturbances, and clinically relevant metabolic outcomes between the follow-up period and the baseline assessment. The exploratory goal is to examine the relationships between changes in risk factors and clinical outcomes in the participants.Read full original descriptionShow less
Epidemiological Survey and Follow-up of Cardiovascular-Kidney-Metabolic Diseases Among Adults in Shanghai
The main purpose of this study is to conduct follow-up assessments and update the cardiorenal outcomes among the STONE cohort that was established during 2016-2017. The secondary aim is to compare metabolic risk factors, metabolic disturbances, and clinically relevant metabolic outcomes between the follow-up period and the baseline assessment. The exploratory goal is to examine the relationships between changes in risk factors and clinical outcomes in the participants.
The study is planned to begin in May 2025 and will finalize the data collection for the entire population by June 2026. During this time, participants will be categorized based on CKM staging. The follow-up phase will continue until 2035.
Inclusion: The 4,094 residents of Shanghai communities who have been enrolled in the STONE cohort; Individuals who completed the baseline questionnaire survey, physical examination, and related clinical tests between 2016 and 2017, with complete data records; Willingness to participate in this follow-up study and provision of informed consent.
Exclusion: Participants who have moved away from their original community and have been living elsewhere for more than two years; Participants whose contact information has changed or become invalid, resulting in loss of contact (those who remain uncontactable after three attempts to reach out).